The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,481 | -35,368 | -19,889 | -83,068 | -64,314 |
| Depreciation Amortization | 8,792 | 5,680 | 2,724 | 26,314 | 25,084 |
| Income taxes - deferred | 0 | 0 | N/A | -76 | 50 |
| Accounts receivable | -12,142 | -11,657 | -16,400 | -4,564 | -8,657 |
| Accounts payable and accrued liabilities | 8,476 | 898 | 6,357 | 5,057 | 3,961 |
| Other Working Capital | 5,325 | -6,138 | -2,732 | 2,359 | -4,087 |
| Other Operating Activity | 10,306 | 15,042 | 14,057 | 17,663 | 15,541 |
| Operating Cash Flow | $-30,724 | $-31,543 | $-15,883 | $-36,315 | $-32,422 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,034 | -2,436 | -610 | -4,567 | -3,706 |
| Net Acquisitions | N/A | N/A | N/A | -4,456 | -4,300 |
| Purchase Of Investment | N/A | N/A | N/A | -9,595 | -9,683 |
| Sale Of Investment | 50,000 | 40,000 | 19,998 | 81,258 | 68,702 |
| Investing Cash Flow | $47,966 | $37,564 | $19,388 | $62,640 | $51,013 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -29 | -18 | -9 | -101 | -91 |
| Common Stock Issued | 75 | 75 | 73 | 126 | 13 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,019 | -1,019 |
| Other Financing Activity | -3,374 | -3,142 | -1,002 | -5,853 | -3,969 |
| Financing Cash Flow | $-3,328 | $-3,085 | $-938 | $-6,847 | $-5,066 |
| Beginning Cash Position | 33,488 | 33,488 | 33,488 | 14,010 | 14,010 |
| End Cash Position | 47,402 | 36,424 | 36,055 | 33,488 | 27,535 |
| Net Cash Flow | $13,914 | $2,936 | $2,567 | $19,478 | $13,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,724 | -31,543 | -15,883 | -36,315 | -32,422 |
| Capital Expenditure | -2,034 | -2,436 | -610 | -4,567 | -3,706 |
| Free Cash Flow | -32,758 | -33,979 | -16,493 | -40,882 | -36,128 |